No Data
Deep Research on shanghai sanyou medical co., ltd(688085): the inflection point of performance has emerged, bullish on the future development of the company.
The company recently disclosed its third quarter report, with revenue for 2024Q1-Q3 decreasing by 7.30% year-on-year, and net income attributable to mother decreasing by 87.07% year-on-year. In Q3, revenue was 0.121 billion yuan, an increase of 57.30% year-on-year.
Shanghai Sanyou Medical Co., Ltd. (688085): The spine and ultrasonic knife business are gradually growing, actively expanding product lines.
Event: In the third quarter of 2024, shanghai sanyou medical co., ltd. achieved revenue of 0.121 billion yuan, a year-on-year increase of 57.30%; achieved a net income attributable to the parent of 6.89 million yuan, a year-on-year surge of 104.53%; In the first three quarters of 2024, shanghai sanyou medical co., ltd.
Sanyou Healthcare: Third Quarter Report 2024
Third Quarter Report 2024
Shanghai Sanyou Medical Co., Ltd. (688085.SH) released its performance for the first three quarters, with a net income of 8.57 million yuan, a year-on-year decrease of 87.07%.
shanghai sanyou medical co., ltd (688085.SH) disclosed the third quarter report of 2024, achieving a revenue of 3....
shanghai sanyou medical co., ltd (688085.SH) appointed Ni Nuan as the CFO.
Shanghai Sanyou Medical Co., Ltd. (688085.SH) announced that the board of directors recently received a letter from Ms. Yang Minhui, the company's CFO...
No Data
No Data